Global Partners Lp Stock Alpha and Beta Analysis
| GLP Stock | USD 42.58 0.27 0.63% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Global Partners LP. It also helps investors analyze the systematic and unsystematic risks associated with investing in Global Partners over a specified time horizon. Remember, high Global Partners' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Global Partners' market risk premium analysis include:
Beta 0.59 | Alpha (0.28) | Risk 1.65 | Sharpe Ratio (0.09) | Expected Return (0.15) |
Global Partners Quarterly Cash And Equivalents |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Global Partners Backtesting, Global Partners Valuation, Global Partners Correlation, Global Partners Hype Analysis, Global Partners Volatility, Global Partners History and analyze Global Partners Performance. Global Partners Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Global Partners market risk premium is the additional return an investor will receive from holding Global Partners long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Global Partners. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Global Partners' performance over market.| α | -0.28 | β | 0.59 |
Global Partners expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Global Partners' Buy-and-hold return. Our buy-and-hold chart shows how Global Partners performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Global Partners Market Price Analysis
Market price analysis indicators help investors to evaluate how Global Partners stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Global Partners shares will generate the highest return on investment. By understating and applying Global Partners stock market price indicators, traders can identify Global Partners position entry and exit signals to maximize returns.
Global Partners Return and Market Media
The median price of Global Partners for the period between Tue, Sep 30, 2025 and Mon, Dec 29, 2025 is 43.95 with a coefficient of variation of 4.1. The daily time series for the period is distributed with a sample standard deviation of 1.81, arithmetic mean of 44.12, and mean deviation of 1.29. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | Alpha Genesis Expands GLP Capacity Following Multi-Million-Dollar Investment to Accelerate IND-Enabling Nonhuman Primate Studies | 10/14/2025 |
2 | Global Partners Dips Following Q3 Results | 11/12/2025 |
| Global Partners dividend paid on 14th of November 2025 | 11/14/2025 |
3 | Acquisition by Global Gp Llc of 3066 shares of Global Partners at 42.96 subject to Rule 16b-3 | 11/20/2025 |
4 | Acquisition by Global Gp Llc of 4005 shares of Global Partners at 42.96 subject to Rule 16b-3 | 11/21/2025 |
5 | Acquisition by Global Gp Llc of 65 shares of Global Partners at 42.05 subject to Rule 16b-3 | 11/24/2025 |
6 | Acquisition by Global Gp Llc of 2228 shares of Global Partners at 42.88 subject to Rule 16b-3 | 11/25/2025 |
7 | Acquisition by Global Gp Llc of 1701 shares of Global Partners at 44.1 subject to Rule 16b-3 | 11/26/2025 |
8 | Acquisition by Global Gp Llc of 1794 shares of Global Partners at 43.97 subject to Rule 16b-3 | 12/01/2025 |
9 | Acquisition by Global Gp Llc of 3809 shares of Global Partners at 43.35 subject to Rule 16b-3 | 12/02/2025 |
10 | Acquisition by Global Gp Llc of 4947 shares of Global Partners at 44.64 subject to Rule 16b-3 | 12/03/2025 |
11 | Acquisition by Global Gp Llc of 5000 shares of Global Partners at 45.21 subject to Rule 16b-3 | 12/04/2025 |
12 | Acquisition by Global Gp Llc of 1450 shares of Global Partners at 45.48 subject to Rule 16b-3 | 12/05/2025 |
13 | Acquisition by Global Gp Llc of 2467 shares of Global Partners at 44.84 subject to Rule 16b-3 | 12/08/2025 |
14 | Acquisition by Global Gp Llc of 2000 shares of Global Partners at 44.16 subject to Rule 16b-3 | 12/11/2025 |
15 | Acquisition by Global Gp Llc of 1463 shares of Global Partners at 43.43 subject to Rule 16b-3 | 12/15/2025 |
16 | Acquisition by Global Gp Llc of 1836 shares of Global Partners at 42.35 subject to Rule 16b-3 | 12/16/2025 |
17 | Acquisition by Global Gp Llc of 2156 shares of Global Partners at 42.02 subject to Rule 16b-3 | 12/17/2025 |
18 | Novo Nordisk files for FDA approval of CagriSema, the first once-weekly combination of GLP1 and amylin analogues for weight management | 12/18/2025 |
19 | Acquisition by Global Gp Llc of 2000 shares of Global Partners at 42.66 subject to Rule 16b-3 | 12/19/2025 |
20 | Acquisition by Global Gp Llc of 1250 shares of Global Partners at 42.98 subject to Rule 16b-3 | 12/22/2025 |
21 | Acquisition by Global Gp Llc of 1080 shares of Global Partners at 43.02 subject to Rule 16b-3 | 12/23/2025 |
About Global Partners Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Global or other stocks. Alpha measures the amount that position in Global Partners LP has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2022 | 2023 | 2024 | 2025 (projected) | Dividend Yield | 0.0851 | 0.1 | 0.0772 | 0.08 | Price To Sales Ratio | 0.0625 | 0.0849 | 0.0918 | 0.047 |
Global Partners Upcoming Company Events
As portrayed in its financial statements, the presentation of Global Partners' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Global Partners' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Global Partners' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Global Partners. Please utilize our Beneish M Score to check the likelihood of Global Partners' management manipulating its earnings.
| 26th of February 2024 Upcoming Quarterly Report | View | |
| 3rd of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 26th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Global Partners
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Global Stock Analysis
When running Global Partners' price analysis, check to measure Global Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Global Partners is operating at the current time. Most of Global Partners' value examination focuses on studying past and present price action to predict the probability of Global Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Global Partners' price. Additionally, you may evaluate how the addition of Global Partners to your portfolios can decrease your overall portfolio volatility.